Cathie Wood’s ARK ETF adjusts portfolio with key stock trades

Cathie Wood’s ARK ETFs have made several notable trades on Friday, March 28th, 2025, with a focus on both buying and selling across various sectors. The trades reflect the ongoing strategy adjustments in the ARK investment portfolios.

The most significant trade of the day was the sale of 350,177 shares of Roblox Corp (NYSE:RBLX), split between ARKK and ARKW ETFs, amounting to a total dollar value of $20,835,531. This move indicates a considerable reduction in ARK’s position in the online gaming platform, which has been a recurring theme as ARK also sold shares of Roblox earlier in the week.

ARK’s next largest transaction involved purchasing 249,423 shares of Robinhood Markets Inc (NASDAQ:HOOD) through its ARKK ETF, with a total dollar value of $10,972,118. This investment suggests a growing confidence in the financial services company, which has been part of ARK’s buying streak in recent days.

On the sell side, ARK also offloaded 224,052 shares of Genius Sports Ltd (NYSE:GENI) through its ARKW ETF, totaling $2,428,723. Additionally, 50,666 shares of Roku Inc (NASDAQ:ROKU) were sold from the same ETF, valued at $3,853,149, and 6,625 shares of Spotify Technology SA (NYSE:SPOT) were sold for a total of $3,843,957. These sales may reflect ARK’s strategy to divest from certain technology and entertainment stocks.

The ARKG ETF saw a sale of 46,940 shares of Repare Therapeutics Inc (NASDAQ:RPTX) for a relatively small dollar value of $50,225, continuing the trend of ARK reducing its position in the biotechnology company throughout the past week.

Lastly, ARK’s ARKW ETF bought a total of 411,875 shares of CoreWeave Inc (NASDAQ:CRWV), although the dollar value of this trade was not provided. This purchase indicates ARK’s interest in expanding its stake in the cloud computing sector.

Investors following ARK’s trading activities will note the consistent pattern of buys and sells, which may offer insights into the ETF’s broader investment strategy. The focus on technology and biotech stocks remains, with specific companies being favored or reduced in the ARK portfolios. As always, these daily trades offer a snapshot of ARK’s dynamic approach to managing their ETFs in the ever-changing market landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.